Mustafa Arici

Time	Session

13:00 14:00	SGLT2 inhibitors: A driving force to improved standard-of-care in CKD Organized by Science Collected. Supported by an unrestricted educational grant from AstraZeneca Carol Pollock Chairperson University of SydneyAustralia Welcome and Introductions Carol Pollock Speaker University of SydneyAustralia Three-pronged protection – mortality, cardiovascular, and kidney benefits with SGLT2 inhibitors Sydney Tang Speaker The University of Hong KongHong Kong, China Old problems, new solutions – practical approaches to optimising care Carol Pollock Speaker University of SydneyAustralia Is it too late? An opportunity to intervene early Mustafa Arici Speaker Panel discussion and Q and A Closing remarks Carol Pollock Speaker University of SydneyAustralia MR 109 CDHG

Time

Session

13:00

14:00

SGLT2 inhibitors: A driving force to improved standard-of-care in CKD

Organized by Science Collected. Supported by an unrestricted educational grant from AstraZeneca

Carol Pollock Chairperson University of SydneyAustralia

Welcome and Introductions

Carol Pollock Speaker University of SydneyAustralia
Three-pronged protection – mortality, cardiovascular, and kidney benefits with SGLT2 inhibitors

Sydney Tang Speaker The University of Hong KongHong Kong, China
Old problems, new solutions – practical approaches to optimising care

Carol Pollock Speaker University of SydneyAustralia
Is it too late? An opportunity to intervene early

Mustafa Arici Speaker
Panel discussion and Q and A
Closing remarks

Carol Pollock Speaker University of SydneyAustralia

MR 109 CDHG